Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Cancer Genetics and Cytogenetics|May 14, 2008
FcgammaRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patientsMárcia Paiva, Herlander Marques, Angelo Martins, et al.
Journal of Neuro-Oncology|October 13, 2006
EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neurofibromatosis type 1 patientsRicardo Ribeiro, Angelo Soares, Daniela Pinto, et al.
Immunobiology|September 23, 2015
Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in PortugalHugo Sousa, Letícia Mesquita, Joana Ribeiro, et al.
DNA and Cell Biology|September 30, 2010
Genetic risk markers for nasopharyngeal carcinoma in Portugal: tumor necrosis factor alpha -308G >A polymorphismHugo Sousa, Eduardo Breda, Alexandra M Santos, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 8, 2013
Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancerHugo Sousa, Sara Oliveira, Alexandra M Santos, et al.
Plos One|March 4, 2014
Circulating Ang-2 mRNA expression levels: looking ahead to a new prognostic factor for NSCLC [corrected]Ana L Coelho, António Araújo, Mónica Gomes, et al.
American Journal of Clinical Oncology|March 2, 2011
Epidermal growth factor genetic variation associated with advanced cervical cancer in younger womenAna Paula Araújo, Raquel Catarino, Ricardo Ribeiro, et al.
Gynecologic and Obstetric Investigation|August 1, 2007
The influence of chemokine receptor CCR2 genotypes in the route to cervical carcinogenesisAna Coelho, Ana Matos, Raquel Catarino, et al.
Acta Otorrinolaringologica Espanola|May 15, 2007
[Characterization of the clinical evolution of nasopharyngeal carcinoma in Portuguese population]Eduardo Breda, Raquel Catarino, Isabel Azevedo, et al.
Pageof 5